The maker of a popular medicine for schizophrenia has notified doctors that it minimized potentially fatal safety risks and made misleading claims about the drug in promotional materials.

Janssen Pharmaceutic Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.

 


Comments


View Comments / Leave a Comment

This post currently has 0 comments.
You can read the comments or leave your own thoughts.


    Last reviewed: By John M. Grohol, Psy.D. on 27 Jul 2004
    Published on PsychCentral.com. All rights reserved.

APA Reference
Grohol, J. (2004). Drug Maker Acknowledges Misleading Claims. Psych Central. Retrieved on December 29, 2014, from http://psychcentral.com/blog/archives/2004/07/27/drug-maker-acknowledges-misleading-claims/

 

Recent Comments
  • skwerl: When you are raised by a toxic parent, it can skew your world view and cause you to be attracted to other...
  • Bacon the question: What is the difference between Judaism and zionism?
  • Traci: OMG this is my marriage.
  • TPG: The low-desire partner always controls. It doesn’t matter whether the issue is about money, about...
  • Oona Gringa: Read about awakening. I’ve had every physical symptom imaginable, and I’m still kicking and...
Subscribe to Our Weekly Newsletter


Find a Therapist
Enter ZIP or postal code



Users Online: 11017
Join Us Now!